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ABSTRACT: This report describes an unprecedented case of a gastric carcinoma with osseous 
metaplasia in an 8-year-old male Standard Poodle. An exploratory laparotomy revealed a firm 
yellowish nodular mass in the pyloric region. The lesion was surgically removed and submitted for 
current histological examination. Immunohistochemistry was performed employing monoclonal 
antibodies for pan-cytokeratin, vimentin, smooth muscular -actin and BMP-2/4. The mass consisted 
in neoplastic proliferation of epithelial cells, arranged in a tubular or acinar pattern and supported by 
scirrhous stroma, with mucin production and multiple foci of heterotopic ossification. Neoplastic 
epithelial cells showed strong positive immunostaining for AE1/AE3 and BMP-2/4, although they were 
negative for both vimentin and -actin. Histopathological findings suggested that the bone tissue may 
be primarily originated from neoplastic epithelial cells which directly circumscribe the osseous 
metaplasia foci.  
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CARCINOMA GÁSTRICO A METAPLASIA ÓSSEA EM UM CÃO 
 
RESUMO: Neste artigo descreve-se um caso inédito de um carcinoma gástrico com metaplasia 
óssea num caniche macho, de oito anos de idade. Através de laparatomia exploratória foi 
cirurgicamente removida uma massa amarelada, nodular e firme na região do piloro. A lesão foi 
enviada para análise histopatológica. Foram realizadas técnicas imunohistoquímicas adicionais, 
sendo empregues os seguintes anticorpos monoclonais: pan-citoqueratinas, vimentina, alfa-actina do 
músculo liso e BMP-2/4. A massa consistia numa proliferação neoplásica de células epiteliais, 
dispostas em arranjos tubulares ou acinares por entre estroma esquirroso, apresentando áreas de 
deposição de mucina e múltiplos focos de ossificação heterotópica. As células epiteliais neoplásicas 
demonstraram forte imunopositividade para a AE1/AE3 e BMP-2/4, não tendo apresentando 
qualquer imunorreactividade para a vimentina e alfa actina do músculo liso. Os achados 
histopatológicos sugerem que o tecido ósseo neoformado deve ser principalmente proveniente das 
células epiteliais neoplásicas que circunscrevem diretamente os focos de metaplasia óssea 
existentes na lesão. 
Palavras-chave: canina; proteínas morfogenéticas ósseas (BMPs), carcinoma gástrico; 
imunohistoquímica; metaplasia óssea 
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INTRODUCTION 
 
 Gastric tumours account for less 
than 1% of all reported neoplasms in 
dogs (Crow, 1985). Carcinoma is the 
most frequent canine gastric neoplasm, 
followed by smooth muscle tumours and 
lymphomas (Head, 1976). Benign 
glandular tumours are less common, 
being generally found as incidental 
lesions at necropsy (Scanziani et al., 
1991). Most gastric carcinomas are 
located in the lesser curvature and 
pylorus, often progressing to involve 
most of the stomach body (Fonda et al., 
1989; Scanziani et al., 1991, Sautter et 
al., 1975; Sullivan et al., 1987).  
 The average age of dogs with 
gastric carcinoma ranges from 7.5 to 
10.2 years (Fonda et al., 1989). Some 
authors report a higher incidence in 
males (Fonda et al., 1989; Scanziani et 
al., 1991) and suggest a breed 
predisposition in Rough Collie, 
Staffordshire Terrier (Sullivan et al., 
1987) and Belgian Shepherd (Sautter et 
al., 1975). Early clinical signs include 
vomiting, weight loss, anorexia, 
diarrhoea, melena, hematemesis and 
dullness (Ogilvie et al., 1995). 
 
MATERIAL AND METHODS 
 
 This short communication 
describes an unprecedented case of 
gastric carcinoma with osseous 
metaplasia in an 8-year-old male 
Standard Poodle. The animal was 
presented for clinical examination with a 
2-week history of vomiting (mostly in the 
morning), not related to food intake, and 
abdominal pain. No substantial 
haematological and biochemical 
changes were observed but on 
abdominal ultrasound examination a 
diffuse mass in the gastric region was 
revealed. An exploratory laparotomy 
confirmed a firm pyloric mass, with 
multiple yellow nodulations. The lesion 
was surgically removed, fixed in 10 per 
cent buffered formalin and submitted for 
histological examination. Supportive 
treatment failed and the animal was 
euthanatized 1-week later upon the 
owner’s request, who did not allow 
necropsy examination. 
 Tissues samples were routinely 
processed, dehydrated and embedded 
in paraffin wax. Consecutive 4µm-
sections were cut and stained with 
haematoxylin and eosin. 
Immunohistochemistry was performed 
using the avidin-biotin-peroxidase 
complex (ABC) method, employing the 
following monoclonal antisera: pan-
cytokeratin (clone AE1/AE3, Zymed) 
diluted 1:50; vimentin (clone V9, Dako) 
diluted 1:100; smooth muscular -actin 
(clone HHF35, Dako) diluted 1:300 and 
bone morphogenetic protein 2/4 (BMP-
2/4) (clone H51, Santa Cruz) diluted 
1:20.  
 
RESULTS 
  
 Histologically, the mass consisted 
of a multinodular neoplastic proliferation 
of well-differentiated epithelial cells, 
arranged in a tubular or acinar pattern 
supported by scirrhous stroma. 
Neoplastic cells presented large, round 
to oval nuclei, with a finely stippled 
chromatin pattern, exhibiting one or two 
prominent nucleoli and abundant 
acidophylic cytoplasm. Some of these 
cells adopted a mucin-filled signet-ring 
morphology. Extracellular mucin 
overproduction was also observed as 
large irregular pools. Mitotic figures were 
frequent (six mitotic figures per high 
power field) some of which were 
atypical. Multiple foci of heterotopic 
ossification, consisting of osteoid and 
fully matured bone tissue, surrounded by 
neoplastic epithelial cells (Fig 1), were 
identified both in the mucosa and 
muscular layers. Neither cytological 
atypia nor mitotic figures were found in 
those osseous foci suggesting that they 
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were of metaplastic origin and did not 
constitute the neoplastic population.  
 
 
 
 
 
 
 
 Neoplastic cells showed strong 
positive immunostaining for AE1/AE3 
and BMP-2/4 (Fig. 2), but not for 
vimentin and smooth mucular -actin, 
while osteoblasts showed only weak 
cytoplasmic immunoexpression for 
BMP-2/4. Multiple neoplastic epithelial 
emboli were also observed. Based on 
histopathological findings a diagnosis of 
gastric carcinoma with osseous 
metaplasia was made. 
 
DISCUSSION 
 
 According to the World Health 
Organization (WHO), canine gastric 
carcinomas are subdivided into 
tubulopapillary, mucinous, signet-ring 
and undifferentiated types, depending 
on the predominant histological picture 
(Head et al., 2003). The WHO 
classification system also includes 
carcinosarcoma (involving both epithelial 
and mesenchymal malignant 
components, sometimes with 
chondroid/osseous differentiation) as a 
rare gastric neoplasm (Teramachi et al., 
2003). In the case here reported, 
neoplastic cells showed 
immunoreactivity for the epithelial 
marker but not for vimentin or -actin, 
thus excluding a putative mesenchymal 
origin. Moreover, the non-neoplastic 
appearance of the osseous foci ruled out 
a possible sarcomatous component.  
 According to several 
investigations, osseous metaplasia has 
been associated with inflammatory 
changes and mucin production and 
(Alper et al., 2000; Haque et al., 1996), 
local ischemia and/or necrosis (Ansari et 
al., 1992). However, although these 
events occur frequently in gastric 
carcinomas, osseous metaplasia 
remains an unusual finding, with only 
very few cases reported in humans 
(Olinici et al., 2002). In veterinary 
medicine, osseous metaplasia in a 
gastric carcinoma has only been 
described in ferrets (Mustela putoris 
furo) (Nakanishi et al., 2005) and in 
pleural and aortic metastases of a 
gastric carcinoma in a camel (Camelus 
ferus bactrianus) (Kunh et al., 2003). 
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 The origin of heterotopic 
ossification in gastrointestinal 
carcinomas is not well understood, and 
some investigators suggest direct 
osseous metaplasia from carcinomatous 
cells (Plenge, 1955), while others 
speculate it may derive from stromal 
fibroblasts (Rhone & Horowitz, 1976). 
 Some studies demonstrated the 
existence of tumour related factors with 
osteogenic properties - BMP´s - that 
may be involved in the formation of 
osseous areas, both within the tumour 
and in metastatic lesions (Goltzman, 
1997; Komai et al., 2006; Liu et al., 
2007). BMP’s are a group of proteins 
belonging to the transforming growth 
factor-beta superfamily, present in the 
bone matrix and recently 16 different 
BMP’s have been identified and 
subdivided according to their structural 
similarity (Dimitriou & Giannoudis, 
2005). When binding to the appropriate 
receptors, they promote mesenchymal 
cell differentiation into osteoblasts 
leading to bone formation (Wang et al., 
1990; Dimitriou & Giannoudis, 2005).  
BMP-2 and BMP-4 are closely related 
molecules and both have the ability to 
induce ectopic bone formation in vivo 
and osteoblastic differentiation (Wang et 
al, 1990; Hanada et al, 1997). Moreover, 
Kypson et al. (2003) documented that 
heterotopic ossification in a human 
rectal carcinoma was associated with an 
BMP-2 overexpression in epithelial 
neoplastic cells. Thus, it has been 
proposed that both neoplastic epithelial 
and mesenchymal cells can produce 
signalling proteins such as BMP’s, 
leading to heterotopic ossification areas 
within tumoral lesions (Liu et al., 2007).  
 In this case, the positive 
immunostaining of carcinomatous 
component for BMP suggests the 
presence of an osteogenic signal 
originated from neoplastic epithelial 
cells. This fact was reinforced by the 
evidence that in normal gastric tissues 
(representing the different anatomical 
areas of canine stomach) no 
imunoexpression of BMP2/4 was found 
neither in epithelial nor in mesenchymal 
cells. Therefore, we hypothesize that the 
bone tissue derived directly from 
neoplastic epithelial cells that 
circumscribe the osseous metaplasia 
foci, creating an autocrine or paracrine 
signal which probably induced the 
differentiation of epithelial, mesenchymal 
or stem cells into osteoblasts.  
 The reason why some neoplasms 
undergo osseous metaplasia while 
others do not is unknown, but it is 
probably a result of a random activation 
with very little growth advantage for 
neoplastic cells (Kypson et al., 2003). 
Otherwise, it would be a more commonly 
finding. 
  
CONCLUSION 
 
 In this report we describe the first 
case of gastric carcinoma with osseous 
metaplasia in a dog and demonstrate for 
the first time the expression of BMP-2/4 
within the epithelial neoplastic cells of a 
canine gastric carcinoma, revealing a 
potential signalling mechanism for 
osteogenic transformation.  
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